Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Brain ageing and disorders of the central nervous system: kynurenines and drug metabolism.
Elevated serum anti-phosphatidylcholine IgG antibodies in patients with influenza vaccination-associated optic neuritis.
The Perspectives of Iranian Patients With Multiple Sclerosis on Continuity of Care: A Qualitative Study.
Is There A Pulse Wave Encephalopathy Component To Multiple Sclerosis?
Madariaga Virus Infection Associated with a Case of Acute Disseminated Encephalomyelitis.
Impaired sleep-associated modulation of post-exercise corticomotor depression in multiple sclerosis.
Statistical colocalization of genetic risk variants for related autoimmune diseases in the context of common controls.
Tumefactive demyelination following herbal supplement use: Cause or coincidence?
The expanded spectrum of neuromyelitis optica: evidences for a new definition.
Disease-modifying drugs for multiple sclerosis must be globally available according to therapeutic guidelines suitable to different regions of the world.
Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis.
How does fingolimod (gilenya(®)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?
Symptoms Related to Tumor Necrosis Factor Receptor 1-associated Periodic Syndrome, Multiple Sclerosis, and Severe Rheumatoid Arthritis in Patients Carrying the TNF Receptor Superfamily 1A D12E/p.Asp41Glu Mutation.
Lessons Learned From Fatal Progressive Multifocal Leukoencephalopathy in a Patient With Multiple Sclerosis Treated With Natalizumab.
Saturable Leptin Transport Across the BBB Persists in EAE Mice.
Neurological diseases in pregnancy.
Ustekinumab in chronic immune-mediated diseases: a review of long term safety and patient improvement.
Limited utility of current MRI criteria for distinguishing multiple sclerosis from common mimickers: primary and secondary CNS vasculitis, lupus and Sjogren's syndrome.
Effects of exercise on Irisin, BDNF and IL-6 serum levels in patients with progressive multiple sclerosis.
Managed care aspects of managing neurogenic bladder/neurogenic detrusor overactivity.
Multiple sclerosis: Could simvastatin slow down secondary progressive MS?
Are There Differences in the Prevalence of Palliative Care-Related Problems in People Living With Advanced Cancer and Eight Non-Cancer Conditions? A Systematic Review.
Th17 and Non-Classic Th1 Cells in Chronic Inflammatory Disorders: Two Sides of the Same Coin.
The multiple sclerosis self-management scale: clinicometric testing.
The central role of mitochondria in axonal degeneration in multiple sclerosis.

Pages